Biotech Sector | Stocks, Companies & Industry Analysis
* Most popular articles from last 3 days
- Genentech's Trastuzumab-Dm1 Shows Great Promise in Treating Breast Cancer
- Why I Pick on Pfizer
- Two Near-Term Biotech Plays
- Good Bye U.S. Savings Bonds, Hello Stem Cells, Farmland and India
- Updated FDA Decision Calendar: Five Decisions Before Year-End
- Two Calculated Risks Possibly Worth Taking
-
Neogen Corporation F2Q09 (Qtr End 11/30/08) Earnings Call Transcript
on Jan 06, 2009 about NEOG
- Aspen BioPharma: Anticipating Active '09
- Until Proven Otherwise, Sticking with Emergent BioSolutions
- Too Much Optimism for Gilead Sciences?
- Six Book-Value Bargains
- 40 Top Rated Emerging Bio-Pharma Stocks
- Stem Cell and Regenerative Medicine Stocks Surge in December
- Healthcare: Investing Trends for 2009
- It May Be 'China's Time' to Leapfrog Ahead in Biopharma
-
Immunogen and Exelixis Defy the Recession
- New Emerging Diagnostics Index
January 07, 2009
| Last Updated
22:08
ET
Get Seeking Alpha Free Stock Alerts by Email!
Get Free Stock Alerts by Email!
Hedge Fund Jobs
Job Seekers: Search jobs by category, get job alerts by email or live feed, apply online See full list of jobs »
Employers: See all recruitment options, get applications online or by email Post a job »